[
    {
        "other_ids": [],
        "amendment_date": "2021-12-17",
        "keywords": null,
        "dcp_id": null,
        "interventional_model": "Parallel",
        "lead_org": "SWOG",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "STEP 1 REGISTRATION: DISEASE-RELATED CRITERIA: All patients must have a histologically or cytologically proven diagnosis of adenocarcinoma of the prostate. Patients with pure small cell carcinoma* (SCC), sarcomatoid, or squamous cell carcinoma are not eligible. (*morphology must be consistent with SCC; synaptophysin or chromogranin positive by immunohistochemical staining is insufficient to diagnose SCC)."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "STEP 1 REGISTRATION: DISEASE-RELATED CRITERIA: Patients must have an intact prostate."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "STEP 1 REGISTRATION: DISEASE-RELATED CRITERIA: Patients must have at least one of the following scans performed, showing evidence of metastatic disease: \r\n* Technetium bone scan OR \r\n* Computed tomography (CT) of abdomen & pelvis OR \r\n* Magnetic resonance imaging (MRI) of pelvis. \r\nThe scan showing metastases must be performed in the range of 42 days before and 14 days following the start of first hormonal therapy.  Metastatic disease that is detected by positron emission tomography (PET) scan only (sodium fluoride [NaF], prostate-specific membrane antigen [PSMA], FACBC, C11) but not conventional imaging (Tc99 bone scan, computed tomography [CT] or magnetic resonance imaging [MRI]) or solitary metastases by conventional imaging, must be confirmed histologically or cytologically."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "STEP 1 REGISTRATION: DISEASE-RELATED CRITERIA: Patients with known brain metastases are not eligible. Brain imaging studies are not required for eligibility if the patient has no neurologic signs or symptoms suggestive of brain metastasis. If brain imaging studies are performed, they must be negative for disease."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "STEP 1 REGISTRATION: PRIOR/CONCURRENT THERAPY CRITERIA: Patients must have received no more than 28 weeks of SST, as measured from the date of first hormonal therapy (luteinizing hormone-releasing hormone [LHRH] agonist or LHRH antagonist) or surgical castration. SST is defined as current National Comprehensive Cancer Network (NCCN) guidelines for metastatic prostate cancer."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "STEP 1 REGISTRATION: PRIOR/CONCURRENT THERAPY CRITERIA: No prior local therapy for prostate adenocarcinoma is allowed (e.g., brachytherapy, high-intensity focused ultrasound ablation [HIFU], cryotherapy, laser ablative therapies). Any prior therapy for benign conditions, such as obstruction, are acceptable (e.g., transurethral resection of the prostate, greenlight laser ablation, microwave ablation)."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "STEP 1 REGISTRATION: PRIOR/CONCURRENT THERAPY CRITERIA: Patients must not have received any prior systemic therapy for prostate cancer, outside of line of SST to be used for duration of study."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "STEP 1 REGISTRATION: PRIOR/CONCURRENT THERAPY CRITERIA: Patients must not have progressed while on SST."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "STEP 1 REGISTRATION: PRIOR/CONCURRENT THERAPY CRITERIA: Patients with oligometastatic prostate cancer may receive metastasis directed therapy to up to four sites of disease prior to randomization."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "STEP 1 REGISTRATION: CLINICAL/LABORATORY CRITERIA: Patients must be >= 18 years of age."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 11,
                    "description": "STEP 1 REGISTRATION: CLINICAL/LABORATORY CRITERIA: Patients must have a complete physical examination and medical history within 28 days prior to registration."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 12,
                    "description": "STEP 1 REGISTRATION: CLINICAL/LABORATORY CRITERIA: Patients must have a documented prostate specific antigen (PSA):\r\n* Prior to initiation of SST\r\n* Within 28 days prior to registration\r\n* Any additional PSAs measured while receiving SST should be recorded."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 13,
                    "description": "STEP 1 REGISTRATION: CLINICAL/LABORATORY CRITERIA: No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, adequately treated stage 0, I or II cancer from which the patient is currently in complete remission, or any other cancer from which the patient has been disease free for three years."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 14,
                    "description": "STEP 1 REGISTRATION: SPECIMEN SUBMISSION CRITERIA: Patients must be offered the opportunity to participate in translational medicine studies and specimen banking for future studies."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 15,
                    "description": "STEP 1 REGISTRATION: QUALITY OF LIFE CRITERIA: Patients who can complete Patient-Reported Outcome instruments in English, Spanish or French, must participate in the quality of life studies."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 16,
                    "description": "STEP 1 REGISTRATION: REGULATORY CRITERIA: Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 17,
                    "description": "STEP 1 REGISTRATION: REGULATORY CRITERIA: As a part of the OPEN registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 18,
                    "description": "STEP 2 RANDOMIZATION: DISEASE-RELATED CRITERIA: Patients must have no evidence of disease progression during the 28 weeks of SST by:\r\n* PSA measure\r\n* Imaging (bone scan and one of the following: CT of abdomen & pelvis, MRI of abdomen & pelvis, CT of abdomen & MRI of pelvis) within 42 days prior to randomization."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 19,
                    "description": "STEP 2 RANDOMIZATION: DISEASE-RELATED CRITERIA: Patients must have no evidence of symptomatic deterioration (as defined by physician discretion) within 28 days prior to randomization."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 20,
                    "description": "STEP 2 RANDOMIZATION: DISEASE-RELATED CRITERIA: Patients must have consultation with a urologist and have surgically resectable disease regardless of definitive treatment intent or randomization."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 21,
                    "description": "STEP 2 RANDOMIZATION: PRIOR/CONCURRENT THERAPY CRITERIA: Patients must have received between 22 and no more than 28 weeks of SST, as measured from the date of first hormonal therapy (LHRH agonist or LHRH antagonist) or surgical castration. SST is defined by current NCCN guidelines for metastatic prostate cancer."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 22,
                    "description": "STEP 2 RANDOMIZATION: PRIOR/CONCURRENT THERAPY CRITERIA: Patients must not be planning to receive docetaxel after randomization."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 23,
                    "description": "STEP 2 RANDOMIZATION: PRIOR/CONCURRENT THERAPY CRITERIA: All SST-related toxicities must have resolved to =< grade 1 (Common Terminology Criteria for Adverse Events [CTCAE] version 5.0) except for fatigue, weight gain, and hot flashes, prior to randomization."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 24,
                    "description": "STEP 2 RANDOMIZATION: PRIOR/CONCURRENT THERAPY CRITERIA: Patients may have received elective metastasis directed therapy to oligometastatic sites (=< 4 sites). All treatment must be completed prior to randomization."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 25,
                    "description": "STEP 2 RANDOMIZATION: CLINICAL/LABORATORY CRITERIA: Patients must have a PSA performed within 28 days prior to randomization."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 26,
                    "description": "STEP 2 RANDOMIZATION: CLINICAL/LABORATORY CRITERIA: Patients must have a testosterone < 50 ng/dL within 28 days prior to randomization."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 27,
                    "description": "STEP 2 RANDOMIZATION: CLINICAL/LABORATORY CRITERIA: Patients must have a Zubrod performance status of 0 \u2013 1 within 28 days prior to randomization."
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "MALE",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "PRIMARY OBJECTIVE:\r\nI. To compare overall survival in metastatic prostate cancer patients who are randomized to standard systemic therapy (SST) plus definitive treatment of the primary tumor versus standard systemic therapy alone.\r\n\r\nSECONDARY OBJECTIVES:\r\nI. To compare overall survival in metastatic prostate cancer patients who received SST plus surgical excision of the primary tumor versus SST alone in the subset who specify the surgical intent stratification factor. \r\nII. To compare the rate of symptomatic local progression between the treatment arms.\r\nIII. To compare progression-free survival (PFS) between the two treatment arms.\r\nIV. To compare rates of progression-free survival between arms for the subsets of patients with and without metastasis directed therapy (MDT) to oligometastatic sites.\r\n\r\nQUALITY OF LIFE OBJECTIVE:\r\nI. To compare between arms patient-reported urinary function and urinary bother over time (after initiation of SST at 6 months, 1, 2, and 3 years) using the Expanded Prostate Cancer Index Composite (EPIC) and patient-reported pain and physical functioning using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) between patients receiving standard systemic therapy and those receiving systemic therapy and definitive management of the primary prostate cancer.\r\n\r\nOTHER OBJECTIVE:\r\nI. To bank tissue and whole blood specimens for future use.\r\n\r\nOUTLINE:\r\n\r\nINDUCTION: Participants receive 1 of 6 acceptable forms of SST for 22-28 weeks.\r\nI. Participants undergo a bilateral orchiectomy.\r\nII. Participants receive goserelin acetate subcutaneously (SC) every 28 days or 12 weeks, histrelin acetate SC every 12 months, leuprolide acetate SC or intramuscularly (IM) every 1, 3, 4, or 6 months, and triptorelin every 1, 3, or 6 months.\r\nIII. Participants receive goserelin acetate SC every 28 days or 12 weeks, histrelin acetate SC every 12 months, leuprolide acetate SC or IM every 1, 3, 4, or 6 months, and triptorelin every 1, 3, or 6 months. Participants also receive nilutamide orally (PO) daily, flutamide PO every 8 hours, and bicalutamide PO daily.\r\nIV. Participants receive degarelix via injection for 2 doses and then every 28 days.\r\nV. Participants receive nilutamide PO daily, flutamide PO every 8 hours, and bicalutamide PO daily. Participants also receive docetaxel over 1 hour every 3 weeks with or without prednisone PO every 12 hours. \r\nVI. Participants receive nilutamide PO daily, flutamide PO every 8 hours, and bicalutamide PO daily. Participants also receive abiraterone PO daily or prednisone PO every 12 hours.\r\n\r\nAfter completion of 22-28 weeks of SST, participants are then randomized to 1 of 2 arms.\r\n\r\nARM I: Participants receive 1 acceptable form of SST as in Induction except for treatment with docetaxel and prednisone. \r\n\r\nARM II: Participants receive 1 acceptable form of SST as in Induction except for treatment with docetaxel and prednisone. Participants undergo prostatectomy within 8 weeks after randomization or radiation therapy within 4 weeks of randomization.\r\n\r\nAfter completion of study treatment, participants are followed up for 8 years.",
        "official_title": "Phase III Randomized Trial of Standard Systemic Therapy (SST) versus Standard Systemic Therapy plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer",
        "_phase_sort_order": 0,
        "collaborators": [
            {
                "name": "National Cancer Institute",
                "functional_role": "FUNDING_SOURCE"
            }
        ],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "From date of randomization to date of death due to any cause, assessed up to 8 years",
                "name": "Median OS",
                "description": "Will compare OS in metastatic prostate cancer patients who received standard systemic therapy (SST) plus surgical excision of the primary tumor versus SST alone in the subset who specify the surgical intent stratification factor.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From date of randomization to date of death due to any cause, assessed up to 8 years",
                "name": "Overall survival (OS)",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "From date of randomization to date of first documentation of progression, or death due to any cause, assessed up to 8 years",
                "name": "Progression-free survival (PFS)",
                "description": "Will be compared between for the subsets of patients with and without metastasis directed therapy (MDT) to oligometastatic sites. A proportional hazards model will be fit to each of these endpoints where the time interval starts at date of randomization to (i) time of first symptomatic local progression or ii) progression or death due to any cause, where those without the event are censored at their last contact date. Stratification factors will be adjusted for as covariates.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 8 years",
                "name": "Rate of symptomatic local progression",
                "description": "Defined as any of the following events post-randomization: Common Terminology Criteria for Adverse Events version 5 grade >= 2 hematuria, urinary retention, urinary tract obstruction, urinary tract pain, pelvic pain, renal and urinary disorders-other. Will be compared between the treatment arms. A proportional hazards model will be fit to each of these endpoints where the time interval starts at date of randomization to (i) time of first symptomatic local progression or ii) progression or death due to any cause, where those without the event are censored at their last contact date. Stratification factors will be adjusted for as covariates.",
                "type_code": "SECONDARY"
            }
        ],
        "phase": "III",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 2,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT03678025",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "EC 3",
                    "Hydrolases"
                ],
                "nci_thesaurus_concept_id": "C16701",
                "name": "Hydrolase",
                "semantic_types": [
                    "Amino Acid, Peptide, or Protein",
                    "Enzyme"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C17021",
                    "C16554",
                    "C16612",
                    "C20027",
                    "C25804",
                    "C21281",
                    "C26548"
                ],
                "parents": [
                    "C16554",
                    "C21281",
                    "C25804"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Proteins [By Function]"
                ],
                "nci_thesaurus_concept_id": "C20027",
                "name": "Protein, Organized by Function",
                "semantic_types": [
                    "Classification"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C17021",
                    "C26548"
                ],
                "parents": [
                    "C17021"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "KLK3",
                    "Kallikrein 3, (Prostate Specific Antigen) Gene",
                    "PSA"
                ],
                "nci_thesaurus_concept_id": "C26585",
                "name": "KLK3 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C26003",
                    "C21281",
                    "C25804",
                    "C16612"
                ],
                "parents": [
                    "C26003"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "Antigen, Prostate-Specific",
                    "EC 3.4.21.77",
                    "Gamma-Seminoprotein",
                    "KLK3",
                    "Kallikrein-3",
                    "P-30 Antigen",
                    "PSA",
                    "Prostate Specific Antigen",
                    "Prostate Specific Antigen Preproprotein",
                    "Prostate-Specific Antigen (PSA)",
                    "Semenogelase",
                    "Seminin"
                ],
                "nci_thesaurus_concept_id": "C17525",
                "name": "Prostate-Specific Antigen",
                "semantic_types": [
                    "Amino Acid, Peptide, or Protein",
                    "Enzyme"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C17021",
                    "C16554",
                    "C16612",
                    "C26585",
                    "C20027",
                    "C25804",
                    "C16965",
                    "C17123",
                    "C26003",
                    "C16701",
                    "C21281",
                    "C26548"
                ],
                "parents": [
                    "C17123",
                    "C21281",
                    "C25804",
                    "C26003",
                    "C26585"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Serine Peptidase",
                    "Serine Proteinase"
                ],
                "nci_thesaurus_concept_id": "C17123",
                "name": "Serine Protease",
                "semantic_types": [
                    "Amino Acid, Peptide, or Protein",
                    "Enzyme"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C17021",
                    "C16554",
                    "C16612",
                    "C20027",
                    "C25804",
                    "C16965",
                    "C26003",
                    "C16701",
                    "C21281",
                    "C26548"
                ],
                "parents": [
                    "C16965",
                    "C21281",
                    "C25804",
                    "C26003"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C157377",
                "name": "Testosterone Level Finding",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C36292",
                    "C77140",
                    "C3367"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Protein (NOS)",
                    "Proteins"
                ],
                "nci_thesaurus_concept_id": "C17021",
                "name": "Protein",
                "semantic_types": [
                    "Amino Acid, Peptide, or Protein"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C26548"
                ],
                "parents": [
                    "C26548"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Hydrolase Family Gene"
                ],
                "nci_thesaurus_concept_id": "C25804",
                "name": "Hydrolase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Enzymes"
                ],
                "nci_thesaurus_concept_id": "C16554",
                "name": "Enzyme",
                "semantic_types": [
                    "Enzyme"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21281",
                    "C20027",
                    "C17021",
                    "C26548"
                ],
                "parents": [
                    "C20027",
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C129259",
                "name": "Castration Levels of Testosterone",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C157377",
                    "C36292",
                    "C77140",
                    "C3367"
                ],
                "parents": [
                    "C157377"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Peptide Hydrolase",
                    "Protease",
                    "Proteases",
                    "Proteinase",
                    "Proteolytic Enzyme"
                ],
                "nci_thesaurus_concept_id": "C16965",
                "name": "Peptidase",
                "semantic_types": [
                    "Amino Acid, Peptide, or Protein",
                    "Enzyme"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C17021",
                    "C16554",
                    "C16612",
                    "C20027",
                    "C25804",
                    "C26003",
                    "C16701",
                    "C21281",
                    "C26548"
                ],
                "parents": [
                    "C16701",
                    "C21281",
                    "C25804",
                    "C26003"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "Testosterone Less than 50 Nanograms per Deciliter",
                    "Testosterone Less than 50 Nanograms/Deciliter"
                ],
                "nci_thesaurus_concept_id": "C157378",
                "name": "Testosterone Less than 50 ng/dL",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C157377",
                    "C77140"
                ],
                "parents": [
                    "C157377"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Protease Gene",
                    "Proteinase Gene"
                ],
                "nci_thesaurus_concept_id": "C26003",
                "name": "Peptidase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21281",
                    "C25804"
                ],
                "parents": [
                    "C25804"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genome Encoded Entity"
                ],
                "nci_thesaurus_concept_id": "C26548",
                "name": "Gene Product",
                "semantic_types": [
                    "Classification"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2018-09-17",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Prostate Carcinoma AJCC v8",
                    "Stage IV Prostate Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140173",
                "name": "Stage IV Prostate Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140163"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVA Prostate Cancer AJCC v8",
                    "Stage IVA Prostate Carcinoma AJCC v8",
                    "IVA"
                ],
                "nci_thesaurus_concept_id": "C140174",
                "name": "Stage IVA Prostate Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140173"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "IVB",
                    "Stage IVB Prostate Carcinoma AJCC v8",
                    "Stage IVB Prostate Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140175",
                "name": "Stage IVB Prostate Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140173"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Prostate Adenocarcinoma"
                ],
                "nci_thesaurus_concept_id": "C8945",
                "name": "Metastatic Prostatic Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8946",
                    "C4124",
                    "C2919"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disorder of Male Reproductive System",
                    "Male Reproductive System Disease"
                ],
                "nci_thesaurus_concept_id": "C27019",
                "name": "Male Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4875"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Tumor",
                    "Tumor, metastatic",
                    "Neoplasm, metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156482",
                "name": "Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36310",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma of Prostate",
                    "Prostate cancer, NOS",
                    "Cancer of Prostate",
                    "Prostate Carcinoma",
                    "Carcinoma of the Prostate",
                    "Cancer of the Prostate"
                ],
                "nci_thesaurus_concept_id": "C4863",
                "name": "Prostate Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C181196",
                    "C7378"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm of the Prostate",
                    "Neoplasm of Prostate",
                    "Prostate Tumor",
                    "Tumor of the Prostate",
                    "Tumor of Prostate"
                ],
                "nci_thesaurus_concept_id": "C3343",
                "name": "Prostate Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3054",
                    "C26865"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Malignant Epithelial Neoplasm",
                    "Epithelial Carcinoma",
                    "Malignant Epithelioma",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Epithelial tumor, malignant",
                    "Epithelioma Malignant"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3709",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, secondary",
                    "Secondary Tumor",
                    "Tumor, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Adenocarcinoma, NOS",
                    "ADENOCARCINOMA, MALIGNANT"
                ],
                "nci_thesaurus_concept_id": "C2852",
                "name": "Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C7132"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Adenocarcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C4124",
                "name": "Metastatic Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Tumor of the Male Reproductive System",
                    "Malignant Male Reproductive System Tumor",
                    "Male reprod. system cancer, NOS",
                    "Malignant Neoplasm of the Male Reproductive System",
                    "Malignant Tumor of Male Reproductive System",
                    "Malignant Neoplasm of Male Reproductive System",
                    "Male reproductive system cancer, NOS"
                ],
                "nci_thesaurus_concept_id": "C8561",
                "name": "Malignant Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3054",
                    "C36076"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Genitourinary Neoplasm",
                    "Genitourinary System Cancer",
                    "Genitourinary Cancer"
                ],
                "nci_thesaurus_concept_id": "C156484",
                "name": "Malignant Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C156482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C181196",
                "name": "Male Reproductive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8561",
                    "C164141"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Genitourinary Disorder",
                    "Urogenital Disease"
                ],
                "nci_thesaurus_concept_id": "C156660",
                "name": "Genitourinary System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Prostate Disease"
                ],
                "nci_thesaurus_concept_id": "C26865",
                "name": "Prostate Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27019"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "infiltrating cancer",
                    "invasive cancer",
                    "Infiltrating Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8505",
                "name": "Invasive Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Genital Disorders",
                    "Reproductive System Disease",
                    "Disorder of Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C4875",
                "name": "Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor of Male Reproductive System",
                    "Tumor of the Male Reproductive System",
                    "Neoplasm of Male Reproductive System",
                    "Neoplasm of the Male Reproductive System",
                    "Male Reproductive System Tumor"
                ],
                "nci_thesaurus_concept_id": "C3054",
                "name": "Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3674",
                    "C27019"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Prostate Carcinoma Metastatic",
                    "Prostate Cancer Metastatic",
                    "Metastatic Prostate Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C8946",
                "name": "Metastatic Prostate Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4863",
                    "C146893"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Neoplasm of Prostate",
                    "Malignant Tumor of the Prostate",
                    "Malignant Neoplasm of the Prostate",
                    "Malignant Prostate Tumor",
                    "Malignant Tumor of Prostate"
                ],
                "nci_thesaurus_concept_id": "C7378",
                "name": "Malignant Prostate Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8561",
                    "C3343"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Genitourinary Cancer",
                    "Metastatic Genitourinary Carcinoma",
                    "Metastatic Urogenital Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C146893",
                "name": "Metastatic Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C164141",
                    "C157774"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36076",
                "name": "Malignant Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C3674"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C164141",
                "name": "Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Reproductive System Tumor",
                    "Neoplasm of Reproductive System",
                    "Reproductive Tumor",
                    "Tumor of the Reproductive System",
                    "Tumor of Reproductive System",
                    "Neoplasm of the Reproductive System",
                    "Reproductive Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C3674",
                "name": "Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156482",
                    "C4875"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Adenocarcinoma of the Prostate",
                    "PRAD",
                    "Adenocarcinoma of Prostate"
                ],
                "nci_thesaurus_concept_id": "C2919",
                "name": "Prostate Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C48596",
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Glandular Cell Epithelium Neoplasm",
                    "Glandular Cell Epithelial Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7132",
                "name": "Glandular Cell Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Malignant Genitourinary System Neoplasm",
                    "Metastatic Genitourinary System Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C157774",
                "name": "Metastatic Genitourinary Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C156484"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C9480",
                "name": "Invasive Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C8505"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Malignancy",
                    "Secondary Cancer"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C36255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Invasive Prostate Carcinoma",
                    "Infiltrating Prostate Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C48596",
                "name": "Invasive Prostate Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9480",
                    "C4863"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor Morphology",
                    "Tumor_Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Prostate Carcinoma by AJCC v8 Stage",
                    "Tumor Stage (Pathologic)"
                ],
                "nci_thesaurus_concept_id": "C140163",
                "name": "Prostate Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4863"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "S1802",
        "active_sites_count": 289,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "17,20-lyase Inhibitor",
                            "CYP17 Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C147923",
                        "name": "CYP17A1 Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C242",
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Lipids"
                        ],
                        "nci_thesaurus_concept_id": "C616",
                        "name": "Lipid",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C718"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Intervention",
                            "Intervention Strategies",
                            "Procedure"
                        ],
                        "nci_thesaurus_concept_id": "C25218",
                        "name": "Intervention or Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C16203"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C43431",
                        "name": "Activity",
                        "description": null,
                        "type": "Radiation",
                        "category": "other",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Prostatovesiculectomy"
                        ],
                        "nci_thesaurus_concept_id": "C15399",
                        "name": "Radical Prostatectomy",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C15307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "GnRH Analog",
                            "GnRH Agonist",
                            "Luteinizing Hormone-Releasing Hormone Analog",
                            "Gonadotropin-Releasing Hormone Analogue",
                            "LH-RH Analogs",
                            "Gonadotropin-Releasing Hormone Agonist"
                        ],
                        "nci_thesaurus_concept_id": "C1910",
                        "name": "Gonadotropin-releasing Hormone Analog",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C548"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C16203",
                        "name": "Clinical or Research Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C43431"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Flutaplex",
                            "Oncosal",
                            "Tafenil",
                            "Fluta-Gry",
                            "Euflex",
                            "Cebatrol",
                            "Eulexine",
                            "Flulem",
                            "Flutan",
                            "Apimid",
                            "Tecnoflut",
                            "Flutamin",
                            "Prostadirex",
                            "Testotard",
                            "Fluken",
                            "Fugerel",
                            "Flutamex",
                            "Cytomid",
                            "Prostogenat",
                            "Flutabene",
                            "Grisetin",
                            "Prostica",
                            "Prostacur",
                            "Flutacan",
                            "Chimax",
                            "Drogenil",
                            "Flucinome",
                            "Profamid"
                        ],
                        "nci_thesaurus_concept_id": "C509",
                        "name": "Flutamide",
                        "description": "A toluidine derivative and nonsteroidal antiandrogen that is structurally related to bicalutamide and nilutamide. Flutamide and its more potent active metabolite 2-hydroxyflutamide competitively block dihydrotestosterone binding at androgen receptors, forming inactive complexes which cannot translocate into the cell nucleus. Formation of inactive receptors inhibits androgen-dependent DNA and protein synthesis, resulting in tumor cell growth arrest or transient tumor regression. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C242",
                            "C1915"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunosuppressive Agents"
                        ],
                        "nci_thesaurus_concept_id": "C574",
                        "name": "Immunosuppressant",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Adrenal Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C2364",
                        "name": "Adrenal Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1636"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C15307",
                        "name": "Prostatectomy",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C15334"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C52011",
                        "name": "Endocrine Surgical Procedure",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C49163",
                            "C64982",
                            "C15445"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Tubulin Binding Agents"
                        ],
                        "nci_thesaurus_concept_id": "C25974",
                        "name": "Tubulin Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C273"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapeutic Agent",
                            "BRM",
                            "Immune Modulators",
                            "Immunomodulatory Agent",
                            "Biomodulators",
                            "Immunomodulators",
                            "Immunopotentiators",
                            "Immune Regulators",
                            "Biological Response Modifier",
                            "Immunomodulating Agent",
                            "Immunotherapy Agent",
                            "Immune Mediators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C16203",
                        "name": "Clinical or Research Activity",
                        "description": null,
                        "type": "Radiation",
                        "category": "other",
                        "parents": [
                            "C43431"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Cancer Radiotherapy",
                            "Radiation",
                            "Therapy, Radiation",
                            "Irradiation",
                            "Irradiated",
                            "Radiotherapeutics",
                            "RT",
                            "Irradiate",
                            "Radiotherapy"
                        ],
                        "nci_thesaurus_concept_id": "C15313",
                        "name": "Radiation Therapy",
                        "description": null,
                        "type": "Radiation",
                        "category": "other",
                        "parents": [
                            "C49236"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Steroid Hormone",
                            "Synthetic Steroids"
                        ],
                        "nci_thesaurus_concept_id": "C1636",
                        "name": "Therapeutic Steroid Hormone",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C548"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Targeted Agent",
                            "Anti-tumor Targeted Therapy Agent",
                            "Molecularly Targeted Therapy Agent",
                            "Targeted Therapeutic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Terpenes"
                        ],
                        "nci_thesaurus_concept_id": "C860",
                        "name": "Terpene Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C552",
                            "C616"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Urinary Tract Surgery",
                            "Urological Surgical Procedure",
                            "Urologic Surgery"
                        ],
                        "nci_thesaurus_concept_id": "C15334",
                        "name": "Urologic Surgical Procedure",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C15333"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Male Castration",
                            "Male Gonadectomy",
                            "Castration"
                        ],
                        "nci_thesaurus_concept_id": "C15288",
                        "name": "Orchiectomy",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C15198"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Therapeutic Method",
                            "Therapeutic Interventions",
                            "Therapy",
                            "Therapeutic Technique",
                            "TX"
                        ],
                        "nci_thesaurus_concept_id": "C49236",
                        "name": "Therapeutic Procedure",
                        "description": null,
                        "type": "Radiation",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Taxotere Injection Concentrate",
                            "Docecad",
                            "Taxotere"
                        ],
                        "nci_thesaurus_concept_id": "C1526",
                        "name": "Docetaxel",
                        "description": "A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree Taxus baccata.  Docetaxel displays potent and broad antineoplastic properties; it binds to and stabilizes tubulin, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and cell death.  This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and displays immunomodulatory and pro-inflammatory properties by inducing various mediators of the inflammatory response.  Docetaxel has been studied for use as a radiation-sensitizing agent. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C67437",
                            "C1490"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Taxane-Site Binding Agent"
                        ],
                        "nci_thesaurus_concept_id": "C67437",
                        "name": "Taxane-Pocket Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C25974"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Intervention",
                            "Intervention Strategies",
                            "Procedure"
                        ],
                        "nci_thesaurus_concept_id": "C25218",
                        "name": "Intervention or Procedure",
                        "description": null,
                        "type": "Radiation",
                        "category": "other",
                        "parents": [
                            "C16203"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1267",
                        "name": "Triptorelin",
                        "description": "A synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH).  Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion. After chronic, continuous administration, this agent effects sustained decreases in LH and FSH production and testicular and ovarian steroidogenesis. Serum testosterone concentrations may fall to levels typically observed in surgically castrated men. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C1910"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C77333",
                        "name": "Abiraterone",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C147923"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antihormone Agents",
                            "Hormone Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C547",
                        "name": "Antihormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Operation",
                            "Surgery",
                            "Surgical Interventions",
                            "Surgical Procedures"
                        ],
                        "nci_thesaurus_concept_id": "C15329",
                        "name": "Surgical Procedure",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Therapeutic Method",
                            "Therapeutic Interventions",
                            "Therapy",
                            "Therapeutic Technique",
                            "TX"
                        ],
                        "nci_thesaurus_concept_id": "C49236",
                        "name": "Therapeutic Procedure",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Intervention",
                            "Intervention Strategies",
                            "Procedure"
                        ],
                        "nci_thesaurus_concept_id": "C25218",
                        "name": "Intervention or Procedure",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C16203"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Prednidib",
                            "Perrigo Prednisone",
                            "Paracort",
                            "Meprosona-F",
                            "Panafcort",
                            "Ofisolona",
                            "Decortisyl",
                            "Panasol-S",
                            "Rayos",
                            "Prednicort",
                            "Deltison",
                            "Promifen",
                            "Prednitone",
                            "Predicorten",
                            "Econosone",
                            "Decorton",
                            "Prednisone Intensol",
                            "Cortancyl",
                            "Deltacortene",
                            "Dacortin",
                            "Predicor",
                            "Servisone",
                            "Predniment",
                            "DeCortin",
                            "Adasone",
                            "Deltra",
                            "Prednilonga"
                        ],
                        "nci_thesaurus_concept_id": "C770",
                        "name": "Prednisone",
                        "description": "A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cell populations. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C521"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hydrocarbons"
                        ],
                        "nci_thesaurus_concept_id": "C552",
                        "name": "Hydrocarbon",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C718"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1915",
                        "name": "Aromatic Compounds",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1933"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Corticosteroids"
                        ],
                        "nci_thesaurus_concept_id": "C211",
                        "name": "Therapeutic Corticosteroid",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2364",
                            "C574"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C49163",
                        "name": "Surgical Procedure by Site or System",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C15329"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C16203",
                        "name": "Clinical or Research Activity",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C43431"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Ablation",
                            "Local Ablation Therapy",
                            "Local Ablative Therapy"
                        ],
                        "nci_thesaurus_concept_id": "C20985",
                        "name": "Ablation Therapy",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C49236"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Therapeutic Method",
                            "Therapeutic Interventions",
                            "Therapy",
                            "Therapeutic Technique",
                            "TX"
                        ],
                        "nci_thesaurus_concept_id": "C49236",
                        "name": "Therapeutic Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Cosudex",
                            "Casodex"
                        ],
                        "nci_thesaurus_concept_id": "C1599",
                        "name": "Bicalutamide",
                        "description": "A synthetic, nonsteroidal antiandrogen.  Bicalutamide competitively binds to cytosolic androgen receptors in target tissues, thereby inhibiting the receptor binding of androgens. This agent does not bind to most mutated forms of androgen receptors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C146993"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Lupron Depot",
                            "Prostap",
                            "Depo-Eligard",
                            "Enantone",
                            "Procrin",
                            "Viadur",
                            "Ginecrin",
                            "Enanton",
                            "Lutrate",
                            "Leuplin",
                            "Lupron Depot-Ped",
                            "Enantone-Gyn",
                            "Procren",
                            "Lupron Depot-3 Month",
                            "Uno-Enantone",
                            "Lupron Depot-4 Month",
                            "Lucrin Depot",
                            "Lupron",
                            "Trenantone",
                            "Lucrin",
                            "Carcinil"
                        ],
                        "nci_thesaurus_concept_id": "C1319",
                        "name": "Leuprolide Acetate",
                        "description": "The acetate salt of a synthetic nonapeptide analogue of gonadotropin-releasing hormone. Leuprolide binds to and activates gonadotropin-releasing hormone (GnRH) receptors. Continuous, prolonged administration of leuprolide in males results in pituitary GnRH receptor desensitization and inhibition of pituitary secretion of follicle stimulating hormone (FSH) and luteinizing hormone (LH), leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. This agent reduces testosterone production to castration levels and may inhibit androgen receptor-positive tumor progression. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C1910"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hormonal Therapy",
                            "Chemotherapy-Hormones/Steroids"
                        ],
                        "nci_thesaurus_concept_id": "C15445",
                        "name": "Hormone Therapy",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C49236"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Glucocorticoid"
                        ],
                        "nci_thesaurus_concept_id": "C521",
                        "name": "Therapeutic Glucocorticoid",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C211"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Nilandron",
                            "Anandron"
                        ],
                        "nci_thesaurus_concept_id": "C1173",
                        "name": "Nilutamide",
                        "description": "A synthetic, nonsteroidal agent with antiandrogenic properties. Nilutamide preferentially binds to androgen receptors and blocks androgen receptor activation by testosterone and other androgens; this agent may inhibit androgen-dependent growth of normal and neoplastic prostate cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C146993"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C15467",
                        "name": "Ablative Endocrine Surgery",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C52011",
                            "C20985"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "GnRH Antagonist",
                            "Gonadotropin Releasing Hormone Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C2092",
                        "name": "Gonadotropin Releasing Hormone Antagonist",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C547"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1933",
                        "name": "Ring Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C718"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C43431",
                        "name": "Activity",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmacologic Agent",
                            "Pharmaceuticals",
                            "Agent",
                            "Pharmacological Substance",
                            "Pharmaceutical Agent",
                            "Drug Substance",
                            "Drug"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C718",
                        "name": "Organic Chemical",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1913"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Firmagon"
                        ],
                        "nci_thesaurus_concept_id": "C48385",
                        "name": "Degarelix",
                        "description": "A long-acting, synthetic peptide with gonadotrophin-releasing hormone (GnRH) antagonistic properties. Degarelix targets and blocks GnRH receptors located on the surfaces of gonadotroph cells in the anterior pituitary, thereby reducing secretion of luteinizing hormone (LH) by pituitary gonadotroph cells and so decreasing  testosterone production by interstitial (Leydig) cells in the testes. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2092"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Agent",
                            "Enzyme Inhibitor Drug"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C64982",
                        "name": "Therapeutic Surgical Procedure",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C15329",
                            "C49236"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1913",
                        "name": "Drug or Chemical by Structure",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Antineoplastic Drugs",
                            "Antiproliferative Drugs",
                            "Anti-Tumor Agents",
                            "Cancer Drug",
                            "Antineoplastics",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Tumor-Specific Treatment Agents"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Castration"
                        ],
                        "nci_thesaurus_concept_id": "C15198",
                        "name": "Surgical Castration",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C15467",
                            "C15333"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Supprelin",
                            "Vantas"
                        ],
                        "nci_thesaurus_concept_id": "C77424",
                        "name": "Histrelin Acetate",
                        "description": "The acetate salt form of histrelin, a long-acting, synthetic nonapeptide analog of gonadotropin-releasing hormone (GnRH) with potential anti-tumor activity. Upon administration, histrelin binds to and activates GnRH receptors; prolonged administration results in pituitary GnRH receptor desensitization and inhibition of follicle stimulating hormone (FSH) and luteinizing hormone (LH) secretion, leading to a significant decline in testosterone production in males and may inhibit androgen receptor-positive tumor progression; in females, prolonged administration results in decreased estradiol production. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C1910"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Taxanes"
                        ],
                        "nci_thesaurus_concept_id": "C1490",
                        "name": "Taxane Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C860"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hormone Therapy Agent",
                            "Hormonal Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C147908",
                        "name": "Hormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Androgen",
                            "Antiandrogens",
                            "Anti-Androgen Agents",
                            "Antiandrogen Agents",
                            "Androgen Antagonists"
                        ],
                        "nci_thesaurus_concept_id": "C242",
                        "name": "Antiandrogen Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C547"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Mitosis Inhibitors",
                            "Antimitotics",
                            "Mitotic Inhibitor Agents",
                            "Microtubular Function Inhibitors",
                            "Mitosis Inhibitor Drugs",
                            "Mitosis Inhibitor Agents",
                            "Mitotic Inhibitors",
                            "Antimitotic Drugs",
                            "Mitotic Inhibitor Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C273",
                        "name": "Antimitotic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Androgen Receptor Antagonist",
                            "AR Inhibitor",
                            "AR Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C146993",
                        "name": "Androgen Receptor Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C242",
                            "C163758"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Genitourinary System Surgical Procedure",
                            "Surgery, Genitourinary",
                            "Urogenital Surgery"
                        ],
                        "nci_thesaurus_concept_id": "C15333",
                        "name": "Urogenital Surgical Procedure",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C49163"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C43431",
                        "name": "Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Zoladex"
                        ],
                        "nci_thesaurus_concept_id": "C1417",
                        "name": "Goserelin Acetate",
                        "description": "The acetate salt of a synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH). Continuous, prolonged administration of goserelin in males results in inhibition of pituitary gonadotropin secretion, leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. (NCI04) Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C1910"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Quality of Life Assessment"
                        ],
                        "nci_thesaurus_concept_id": "C15584",
                        "name": "Quality-of-Life Assessment",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C15747"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Symptom Management",
                            "Therapy, Supportive",
                            "Supportive Therapy"
                        ],
                        "nci_thesaurus_concept_id": "C15747",
                        "name": "Supportive Care",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C49236"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Synthetic Hormone"
                        ],
                        "nci_thesaurus_concept_id": "C548",
                        "name": "Therapeutic Hormone",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908"
                        ]
                    }
                ],
                "name": "Arm II (SST, prostatectomy or radiation therapy)",
                "description": "Participants receive 1 acceptable form of SST as in Induction except for treatment with docetaxel and prednisone. Participants undergo prostatectomy within 8 weeks after randomization or radiation therapy within 4 weeks of randomization.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "17,20-lyase Inhibitor",
                            "CYP17 Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C147923",
                        "name": "CYP17A1 Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C242",
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Lipids"
                        ],
                        "nci_thesaurus_concept_id": "C616",
                        "name": "Lipid",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C718"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Intervention",
                            "Intervention Strategies",
                            "Procedure"
                        ],
                        "nci_thesaurus_concept_id": "C25218",
                        "name": "Intervention or Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C16203"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "GnRH Analog",
                            "GnRH Agonist",
                            "Luteinizing Hormone-Releasing Hormone Analog",
                            "Gonadotropin-Releasing Hormone Analogue",
                            "LH-RH Analogs",
                            "Gonadotropin-Releasing Hormone Agonist"
                        ],
                        "nci_thesaurus_concept_id": "C1910",
                        "name": "Gonadotropin-releasing Hormone Analog",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C548"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C16203",
                        "name": "Clinical or Research Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C43431"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Flutaplex",
                            "Oncosal",
                            "Tafenil",
                            "Fluta-Gry",
                            "Euflex",
                            "Cebatrol",
                            "Eulexine",
                            "Flulem",
                            "Flutan",
                            "Apimid",
                            "Tecnoflut",
                            "Flutamin",
                            "Prostadirex",
                            "Testotard",
                            "Fluken",
                            "Fugerel",
                            "Flutamex",
                            "Cytomid",
                            "Prostogenat",
                            "Flutabene",
                            "Grisetin",
                            "Prostica",
                            "Prostacur",
                            "Flutacan",
                            "Chimax",
                            "Drogenil",
                            "Flucinome",
                            "Profamid"
                        ],
                        "nci_thesaurus_concept_id": "C509",
                        "name": "Flutamide",
                        "description": "A toluidine derivative and nonsteroidal antiandrogen that is structurally related to bicalutamide and nilutamide. Flutamide and its more potent active metabolite 2-hydroxyflutamide competitively block dihydrotestosterone binding at androgen receptors, forming inactive complexes which cannot translocate into the cell nucleus. Formation of inactive receptors inhibits androgen-dependent DNA and protein synthesis, resulting in tumor cell growth arrest or transient tumor regression. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C242",
                            "C1915"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunosuppressive Agents"
                        ],
                        "nci_thesaurus_concept_id": "C574",
                        "name": "Immunosuppressant",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Adrenal Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C2364",
                        "name": "Adrenal Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1636"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C52011",
                        "name": "Endocrine Surgical Procedure",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C49163",
                            "C64982",
                            "C15445"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Tubulin Binding Agents"
                        ],
                        "nci_thesaurus_concept_id": "C25974",
                        "name": "Tubulin Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C273"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapeutic Agent",
                            "BRM",
                            "Immune Modulators",
                            "Immunomodulatory Agent",
                            "Biomodulators",
                            "Immunomodulators",
                            "Immunopotentiators",
                            "Immune Regulators",
                            "Biological Response Modifier",
                            "Immunomodulating Agent",
                            "Immunotherapy Agent",
                            "Immune Mediators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Steroid Hormone",
                            "Synthetic Steroids"
                        ],
                        "nci_thesaurus_concept_id": "C1636",
                        "name": "Therapeutic Steroid Hormone",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C548"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Targeted Agent",
                            "Anti-tumor Targeted Therapy Agent",
                            "Molecularly Targeted Therapy Agent",
                            "Targeted Therapeutic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Terpenes"
                        ],
                        "nci_thesaurus_concept_id": "C860",
                        "name": "Terpene Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C552",
                            "C616"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Male Castration",
                            "Male Gonadectomy",
                            "Castration"
                        ],
                        "nci_thesaurus_concept_id": "C15288",
                        "name": "Orchiectomy",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C15198"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Taxotere Injection Concentrate",
                            "Docecad",
                            "Taxotere"
                        ],
                        "nci_thesaurus_concept_id": "C1526",
                        "name": "Docetaxel",
                        "description": "A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree Taxus baccata.  Docetaxel displays potent and broad antineoplastic properties; it binds to and stabilizes tubulin, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and cell death.  This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and displays immunomodulatory and pro-inflammatory properties by inducing various mediators of the inflammatory response.  Docetaxel has been studied for use as a radiation-sensitizing agent. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C67437",
                            "C1490"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Taxane-Site Binding Agent"
                        ],
                        "nci_thesaurus_concept_id": "C67437",
                        "name": "Taxane-Pocket Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C25974"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1267",
                        "name": "Triptorelin",
                        "description": "A synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH).  Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion. After chronic, continuous administration, this agent effects sustained decreases in LH and FSH production and testicular and ovarian steroidogenesis. Serum testosterone concentrations may fall to levels typically observed in surgically castrated men. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C1910"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C77333",
                        "name": "Abiraterone",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C147923"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antihormone Agents",
                            "Hormone Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C547",
                        "name": "Antihormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Operation",
                            "Surgery",
                            "Surgical Interventions",
                            "Surgical Procedures"
                        ],
                        "nci_thesaurus_concept_id": "C15329",
                        "name": "Surgical Procedure",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Therapeutic Method",
                            "Therapeutic Interventions",
                            "Therapy",
                            "Therapeutic Technique",
                            "TX"
                        ],
                        "nci_thesaurus_concept_id": "C49236",
                        "name": "Therapeutic Procedure",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Intervention",
                            "Intervention Strategies",
                            "Procedure"
                        ],
                        "nci_thesaurus_concept_id": "C25218",
                        "name": "Intervention or Procedure",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C16203"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Prednidib",
                            "Perrigo Prednisone",
                            "Paracort",
                            "Meprosona-F",
                            "Panafcort",
                            "Ofisolona",
                            "Decortisyl",
                            "Panasol-S",
                            "Rayos",
                            "Prednicort",
                            "Deltison",
                            "Promifen",
                            "Prednitone",
                            "Predicorten",
                            "Econosone",
                            "Decorton",
                            "Prednisone Intensol",
                            "Cortancyl",
                            "Deltacortene",
                            "Dacortin",
                            "Predicor",
                            "Servisone",
                            "Predniment",
                            "DeCortin",
                            "Adasone",
                            "Deltra",
                            "Prednilonga"
                        ],
                        "nci_thesaurus_concept_id": "C770",
                        "name": "Prednisone",
                        "description": "A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cell populations. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C521"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hydrocarbons"
                        ],
                        "nci_thesaurus_concept_id": "C552",
                        "name": "Hydrocarbon",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C718"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1915",
                        "name": "Aromatic Compounds",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1933"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Corticosteroids"
                        ],
                        "nci_thesaurus_concept_id": "C211",
                        "name": "Therapeutic Corticosteroid",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2364",
                            "C574"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C49163",
                        "name": "Surgical Procedure by Site or System",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C15329"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C16203",
                        "name": "Clinical or Research Activity",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C43431"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Ablation",
                            "Local Ablation Therapy",
                            "Local Ablative Therapy"
                        ],
                        "nci_thesaurus_concept_id": "C20985",
                        "name": "Ablation Therapy",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C49236"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Therapeutic Method",
                            "Therapeutic Interventions",
                            "Therapy",
                            "Therapeutic Technique",
                            "TX"
                        ],
                        "nci_thesaurus_concept_id": "C49236",
                        "name": "Therapeutic Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Cosudex",
                            "Casodex"
                        ],
                        "nci_thesaurus_concept_id": "C1599",
                        "name": "Bicalutamide",
                        "description": "A synthetic, nonsteroidal antiandrogen.  Bicalutamide competitively binds to cytosolic androgen receptors in target tissues, thereby inhibiting the receptor binding of androgens. This agent does not bind to most mutated forms of androgen receptors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C146993"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Lupron Depot",
                            "Prostap",
                            "Depo-Eligard",
                            "Enantone",
                            "Procrin",
                            "Viadur",
                            "Ginecrin",
                            "Enanton",
                            "Lutrate",
                            "Leuplin",
                            "Lupron Depot-Ped",
                            "Enantone-Gyn",
                            "Procren",
                            "Lupron Depot-3 Month",
                            "Uno-Enantone",
                            "Lupron Depot-4 Month",
                            "Lucrin Depot",
                            "Lupron",
                            "Trenantone",
                            "Lucrin",
                            "Carcinil"
                        ],
                        "nci_thesaurus_concept_id": "C1319",
                        "name": "Leuprolide Acetate",
                        "description": "The acetate salt of a synthetic nonapeptide analogue of gonadotropin-releasing hormone. Leuprolide binds to and activates gonadotropin-releasing hormone (GnRH) receptors. Continuous, prolonged administration of leuprolide in males results in pituitary GnRH receptor desensitization and inhibition of pituitary secretion of follicle stimulating hormone (FSH) and luteinizing hormone (LH), leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. This agent reduces testosterone production to castration levels and may inhibit androgen receptor-positive tumor progression. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C1910"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hormonal Therapy",
                            "Chemotherapy-Hormones/Steroids"
                        ],
                        "nci_thesaurus_concept_id": "C15445",
                        "name": "Hormone Therapy",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C49236"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Glucocorticoid"
                        ],
                        "nci_thesaurus_concept_id": "C521",
                        "name": "Therapeutic Glucocorticoid",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C211"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Nilandron",
                            "Anandron"
                        ],
                        "nci_thesaurus_concept_id": "C1173",
                        "name": "Nilutamide",
                        "description": "A synthetic, nonsteroidal agent with antiandrogenic properties. Nilutamide preferentially binds to androgen receptors and blocks androgen receptor activation by testosterone and other androgens; this agent may inhibit androgen-dependent growth of normal and neoplastic prostate cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C146993"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C15467",
                        "name": "Ablative Endocrine Surgery",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C52011",
                            "C20985"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "GnRH Antagonist",
                            "Gonadotropin Releasing Hormone Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C2092",
                        "name": "Gonadotropin Releasing Hormone Antagonist",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C547"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1933",
                        "name": "Ring Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C718"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C43431",
                        "name": "Activity",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmacologic Agent",
                            "Pharmaceuticals",
                            "Agent",
                            "Pharmacological Substance",
                            "Pharmaceutical Agent",
                            "Drug Substance",
                            "Drug"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C718",
                        "name": "Organic Chemical",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1913"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Firmagon"
                        ],
                        "nci_thesaurus_concept_id": "C48385",
                        "name": "Degarelix",
                        "description": "A long-acting, synthetic peptide with gonadotrophin-releasing hormone (GnRH) antagonistic properties. Degarelix targets and blocks GnRH receptors located on the surfaces of gonadotroph cells in the anterior pituitary, thereby reducing secretion of luteinizing hormone (LH) by pituitary gonadotroph cells and so decreasing  testosterone production by interstitial (Leydig) cells in the testes. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2092"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Agent",
                            "Enzyme Inhibitor Drug"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C64982",
                        "name": "Therapeutic Surgical Procedure",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C15329",
                            "C49236"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1913",
                        "name": "Drug or Chemical by Structure",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Antineoplastic Drugs",
                            "Antiproliferative Drugs",
                            "Anti-Tumor Agents",
                            "Cancer Drug",
                            "Antineoplastics",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Tumor-Specific Treatment Agents"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Castration"
                        ],
                        "nci_thesaurus_concept_id": "C15198",
                        "name": "Surgical Castration",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C15467",
                            "C15333"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Supprelin",
                            "Vantas"
                        ],
                        "nci_thesaurus_concept_id": "C77424",
                        "name": "Histrelin Acetate",
                        "description": "The acetate salt form of histrelin, a long-acting, synthetic nonapeptide analog of gonadotropin-releasing hormone (GnRH) with potential anti-tumor activity. Upon administration, histrelin binds to and activates GnRH receptors; prolonged administration results in pituitary GnRH receptor desensitization and inhibition of follicle stimulating hormone (FSH) and luteinizing hormone (LH) secretion, leading to a significant decline in testosterone production in males and may inhibit androgen receptor-positive tumor progression; in females, prolonged administration results in decreased estradiol production. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C1910"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Taxanes"
                        ],
                        "nci_thesaurus_concept_id": "C1490",
                        "name": "Taxane Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C860"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hormone Therapy Agent",
                            "Hormonal Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C147908",
                        "name": "Hormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Androgen",
                            "Antiandrogens",
                            "Anti-Androgen Agents",
                            "Antiandrogen Agents",
                            "Androgen Antagonists"
                        ],
                        "nci_thesaurus_concept_id": "C242",
                        "name": "Antiandrogen Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C547"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Mitosis Inhibitors",
                            "Antimitotics",
                            "Mitotic Inhibitor Agents",
                            "Microtubular Function Inhibitors",
                            "Mitosis Inhibitor Drugs",
                            "Mitosis Inhibitor Agents",
                            "Mitotic Inhibitors",
                            "Antimitotic Drugs",
                            "Mitotic Inhibitor Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C273",
                        "name": "Antimitotic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Androgen Receptor Antagonist",
                            "AR Inhibitor",
                            "AR Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C146993",
                        "name": "Androgen Receptor Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C242",
                            "C163758"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Genitourinary System Surgical Procedure",
                            "Surgery, Genitourinary",
                            "Urogenital Surgery"
                        ],
                        "nci_thesaurus_concept_id": "C15333",
                        "name": "Urogenital Surgical Procedure",
                        "description": null,
                        "type": "Procedure/Surgery",
                        "category": "other",
                        "parents": [
                            "C49163"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C43431",
                        "name": "Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Zoladex"
                        ],
                        "nci_thesaurus_concept_id": "C1417",
                        "name": "Goserelin Acetate",
                        "description": "The acetate salt of a synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH). Continuous, prolonged administration of goserelin in males results in inhibition of pituitary gonadotropin secretion, leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. (NCI04) Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C1910"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Quality of Life Assessment"
                        ],
                        "nci_thesaurus_concept_id": "C15584",
                        "name": "Quality-of-Life Assessment",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C15747"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Symptom Management",
                            "Therapy, Supportive",
                            "Supportive Therapy"
                        ],
                        "nci_thesaurus_concept_id": "C15747",
                        "name": "Supportive Care",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C49236"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Synthetic Hormone"
                        ],
                        "nci_thesaurus_concept_id": "C548",
                        "name": "Therapeutic Hormone",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908"
                        ]
                    }
                ],
                "name": "Arm I (SST)",
                "description": "Participants receive 1 acceptable form of SST as in Induction except for treatment with docetaxel and prednisone.",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2018-01738",
        "why_study_stopped": null,
        "brief_summary": "This phase III trial compare the effects of adding definitive treatment (either radiation therapy or prostate removal surgery) to standard systemic therapy in treating patients with prostate cancer that has spread to other places in the body (advanced). Removing the prostate by either surgery or radiation therapy in addition to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.",
        "brief_title": "Comparing the Outcome of Standard Systemic Therapy Only versus Standard Systemic therapy with either Surgery or Radiation Therapy, for Patients with Advanced Prostate cancer",
        "status_history": [
            {
                "status_date": "2018-09-17T00:00:00.000002",
                "status": "ACTIVE"
            },
            {
                "status_date": "2018-08-30T00:00:00.000001",
                "status": "APPROVED"
            },
            {
                "status_date": "2018-03-09T00:00:00",
                "status": "IN_REVIEW"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 1273,
        "_current_trial_status_sort_order": 0,
        "start_date": "2018-09-17",
        "record_verification_date": "2022-02-18",
        "ctep_id": "S1802",
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Randomized Controlled Trial"
        },
        "acronym": null,
        "nci_funded": "Direct",
        "anatomic_sites": [
            "Prostate"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": "Brian Francis Chapin",
        "study_source": "National",
        "completion_date": "2028-04-01",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]